Exact Sciences Corporation
EXAS
$56.95
$0.470.83%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -101.22M | -864.59M | -38.24M | -15.81M | -110.23M |
Total Depreciation and Amortization | 54.06M | 53.15M | 54.77M | 53.00M | 53.94M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 79.80M | 879.97M | 77.76M | 40.63M | 82.18M |
Change in Net Operating Assets | -1.84M | -21.47M | 44.43M | 29.24M | -108.21M |
Cash from Operations | 30.81M | 47.06M | 138.72M | 107.07M | -82.31M |
Capital Expenditure | -31.17M | -36.32M | -26.16M | -35.87M | -37.65M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | 0.00 | -45.00M | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -3.26M | -5.56M | -10.56M | -111.26M | -133.79M |
Cash from Investing | -34.44M | -41.87M | -81.72M | -147.13M | -171.44M |
Total Debt Issued | -- | 0.00 | 0.00 | 266.75M | -- |
Total Debt Repaid | -- | 0.00 | 0.00 | -50.00M | -- |
Issuance of Common Stock | -- | 12.71M | 2.13M | 19.40M | -- |
Repurchase of Common Stock | -- | -- | -- | -1.37M | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -256.17M | -2.21M | -2.36M | -10.18M | -3.00M |
Cash from Financing | -256.17M | 10.50M | -226.00K | 224.60M | -3.00M |
Foreign Exchange rate Adjustments | 290.00K | -3.72M | 1.87M | -306.00K | -1.14M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -259.51M | 11.97M | 58.65M | 184.23M | -257.89M |